What Can We Do About Cardiogenic Shock?

Gershlick, Anthony H; Banning, Amerjeet S

Gershlick, Anthony H; Banning, Amerjeet S.

Affiliation

Gershlick AH; From the Leicester Cardiovascular Biomedical Research Centre, University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom. agershlick@aol.com.
Banning AS; From the Leicester Cardiovascular Biomedical Research Centre, University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Circ Cardiovasc Interv ; 10(11)2017 11.

Article in En | MEDLINE | ID: mdl-29146673

Subject(s)

Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Humans; Shock, Cardiogenic

Key words

Editorials; acute coronary syndrome; coronary occlusion; heart rate; shock, cardiogenic; tocilizumab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction Limits: Humans Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2017 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google